Oncology
News
Subcutaneous or IV trastuzumab? Take your pick
Long-term follow-up of women with early, HER2-positive breast cancer showed similar efficacy and safety for subcutaneous or intravenous...
Conference Coverage
Calcium supplement use linked to cancer death
PHILADELPHIA – Multiply dairy servings by 300 g to get a ballpark estimate of calcium intake.
Article
Acute Encephalopathy Following Hyperbaric Oxygen Therapy in a Patient on Metronidazole
This case describes a patient who presented to the emergency department for an
acute onset of encephalopathy following hyperbaric oxygen...
Conference Coverage
Preclinical findings highlight value of Lynch syndrome for cancer vaccine development
ATLANTA – Lynch syndrome is serving as a platform for the development of immunoprevention cancer vaccines.
Conference Coverage
CAR T cells home in on HER2 in advanced sarcomas
ATLANTA – A teenage girl with advanced osteosarcoma has had a durable complete remission after receiving CAR T cells targeted to HER2.
Conference Coverage
Genetic variant increases stroke risk in childhood cancer survivors
ATLANTA - Dr. Yadav Sapkota of St. Jude Children's Research Hospital discusses the identification of a genetic variant that is strongly associated...
News
FDA proposes updates to mammography regulations
Key among the proposed changes is the addition of breast density information to notices for both patients and doctors.
News
Study eyes biomarkers of regorafenib response in hepatocellular carcinoma
Among 266 proteins tested, decreased levels of 5 correlated with significantly longer overall survival on regorafenib therapy.
Conference Coverage
FDA panel calls for changes to breast implant rupture screening
The advisory panel seemed the current implant screening recommendation using MRI “useless.” They urged the adoption of ultrasound as a more...
Conference Coverage
FDA panel leans toward more robust breast implant surveillance
SILVER SPRING, MD. – Amid concern over two breast implant complications – anaplastic large cell lymphoma and autoimmune symptoms – an FDA panel...
